APW
ALNY icon

Aventura Private Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

Aventura Private Wealth’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5K Buy
78
+38
+95% +$11.5K 0.01% 458
2026
Q1 		$13.2K Hold
40
– – ﹤0.01% 507
2025
Q4 		$15.9K Hold
40
– – 0.01% 451
2025
Q3 		$18.2K Hold
40
– – 0.01% 412
2025
Q2 		$13K Buy
40
+10
+33% +$2.77K 0.01% 433
2025
Q1 		$8.1K Hold
30
– – ﹤0.01% 476
2024
Q4 		$7.06K Buy
+30
New +$7.89K ﹤0.01% 480

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aventura Private Wealth's ALNY Position: Q2 2026 in Review

Aventura Private Wealth increased its Alnylam Pharmaceuticals (ALNY) stake by 95% in Q2 2026, buying an estimated $11.5K and bringing the position to 78 shares worth $23.5K. The position accounts for 0.01% of the portfolio, ranked #458.

Aventura Private Wealth first reported a position in ALNY in Q4 2024 and has held it in 7 quarters since. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Aventura Private Wealth held 78 shares of Alnylam Pharmaceuticals worth $23.5K as of Q2 2026.
  • Aventura Private Wealth bought 38 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $11.5K.
  • Alnylam Pharmaceuticals made up 0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #458 holding.
  • Aventura Private Wealth first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.